Published on in Vol 23 , No 12 (2021) :December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34051, first published .
Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Citation Advantage of Promoted Articles in a Cross-Publisher Distribution Platform: 36-Month Follow-up to a Randomized Controlled Trial

Paul Kudlow 1 * , MD, PhD ;   Tashauna Brown 2 * , MSc, PhD ;   Gunther Eysenbach 3 * , MD, MPH

1 Department of Psychiatry , University of Toronto , Toronto , ON , CA

2 TrendMD Inc. , Toronto , ON , CA

3 University of Victoria , Victoria , BC , CA

*all authors contributed equally

Corresponding Author: